InflaRx IFRX
NASDAQ IFRX
$1.53 -0.02 (-1.29%)
At close: Oct 22, 2026 · 4:00 PM EDT

InflaRx (IFRX) Return on Assets [ROA] (2017 - 2026)

Updated

InflaRx's Return on Assets [ROA] came in at -42285304.69% for Q2 2026, down 42285197.67 percentage points from -107.02% a year earlier but up 45146110.58 percentage points from the prior quarter.

Analysis

InflaRx (IFRX) Return on Assets [ROA] (2017 - 2026) Analysis & Trends

For FY2025, InflaRx's Return on Assets [ROA] was -71798698.36%, down 25045435.49 percentage points from FY2024.

  • Return on Assets [ROA] has declined in each of the last three years, with a five-year change of -38220327.54 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Assets [ROA] was -46753262.87% in FY2024 (-7484056.50 pp), -39269206.37% in FY2023 (-14973459.71 pp), -24295746.66% in FY2022 (+17743914.44 pp) and -42039661.10% in FY2021 (-8461290.27 pp).
  • The five-year range for quarterly Return on Assets [ROA] is -87431415.26% (Q1 2026) to -41.31% (Q3 2023).
  • Year-over-year, Return on Assets [ROA] has declined for 11 consecutive quarters, with an average year-over-year change of -25670090.22 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q4 2021 (a gain of 36253077.56 percentage points), and the weakest in Q1 2026 (a drop of 87431308.70 percentage points).
  • Business Quant data shows IFRX's Return on Assets [ROA] at -87431415.26% (Q1 2026), -75644120.36% (Q4 2025) and -111.26% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 8.08%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 4.65%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 2.45%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 10.60%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 9.10%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 9.29%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -6.13%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 2.14%
10 InflaRx 103.29 Mn -230.33 Mn 2.74 Mn -37.01%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.01%
Mar 31, 2026 -82.04%
Dec 31, 2025 -73.30%
Sep 30, 2025 -55.24%
Jun 30, 2025 -55.16%
Mar 31, 2025 -55.77%
Dec 31, 2024 -59.56%
Sep 30, 2024 -65.42%
Jun 30, 2024 -47.07%
Mar 31, 2024 -35.93%
Dec 31, 2023 -34.16%
Sep 30, 2023 -26.40%
Jun 30, 2023 -31.01%
Mar 31, 2023 -27.13%
Dec 31, 2022 -28.75%
Sep 30, 2022 -32.93%
Jun 30, 2022 -35.40%
Mar 31, 2022 -46.06%
Dec 31, 2021 -36.94%
Sep 30, 2021 -32.15%
API Access

InflaRx Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IFRX&period=max&api_key=YOUR_API_KEY